Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

1 year ago 42
Read Entire Article
  1. Homepage
  2. Finance
  3. Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

Related

Israel Q1 GDP shrinks 3.3% annualised as Iran war weighs

Israel Q1 GDP shrinks 3.3% annualised as Iran war weighs

1 hour ago 0
Brazil’s Lula aims to develop relationship with Trump, Washington Post reports

Brazil’s Lula aims to develop relationship with Trump, Washi...

1 hour ago 0
Analysis-Bond yield spike is risk to unprepared equities market, investors warn

Analysis-Bond yield spike is risk to unprepared equities mar...

1 hour ago 0

Trending

1. sulfuric acid
2. fda straus ice cream recall
3. powerball numbers last night
4. weather miami
5. luke shaw
6. maxx crosby
7. ann li
8. maria sakkari
9. gen z years
10. gen z

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

1 year ago 732
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

1 year ago 594
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

1 year ago 460
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

1 year ago 458
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

1 year ago 407
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2026. All rights are reserved